QuadraMed Corporation Market Share Analysis

Publisher Name :
Date: 12-Dec-2012
No. of pages: 45
Inquire Before Buying

QuadraMed Corporation Market Share Analysis

Summary

GlobalData’s new report, “QuadraMed Corporation Market Share Analysis” provides in-depth information on QuadraMed Corporation.’s market position in the clinical IT systems market. The report also provides data and information on the overall competitive landscape within the clinical IT systems market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the clinical IT systems market.
- QuadraMed Corporation.’s company shares (in Revenues) information for all the key countries the company has presence in – Canada and United States.
- QuadraMed Corporation.’s company shares (in Revenues) information for the clinical IT systems market.
- All the key data-points are for 2011 and cover all the key region – North America.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, QuadraMed Corporation.’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to QuadraMed Corporation.’s market positions.

QuadraMed Corporation Market Share Analysis

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
3 Definitions of Markets/Categories Covered 7
3.1 Healthcare IT 7
3.1.1 Clinical IT Systems 7
4 Company Snapshot 8
4.1 Key Information 8
4.2 Company Overview 8
4.3 SWOT Snapshot 8
4.4 Business Overview 9
4.5 Major Products and Services 10
4.5.1 Overview 10
5 History 11
6 SWOT Analysis 13
6.1 Overview 13
6.2 QuadraMed Corporation Strengths 13
6.2.1 Industry Recognitions 13
6.2.2 Exhaustive Suite of Consulting Services 14
6.2.3 Extensive Product Range 14
6.3 QuadraMed Corporation Weaknesses 14
6.3.1 Involvement in Legal Proceedings 14
6.4 QuadraMed Corporation Opportunities 15
6.4.1 Growth Prospects: Healthcare IT 15
6.4.2 New Business Contracts 15
6.4.3 Strategic Acquisition 15
6.5 QuadraMed Corporation Threats 16
6.5.1 Government Regulations 16
6.5.2 Competitive Landscape 16
6.5.3 Rapid Technological Advancements 16
7 Competitors 17
8 Competitive Landscape 19
8.1 Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 19
8.2 QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Region, Market Share (2011) 21
8.3 QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Country, Market Share (2011) 22
9 Key Employees 23
10 Key Employee Biographies 24
11 Company Statement 25
12 Locations And Subsidiaries 26
12.1 Head Office 26
13 Financial Deals Landscape 27
13.1 QuadraMed Corporation, Deals Volume Summary, 2006 to YTD 2012 27
14 QuadraMed Corporation Detailed Deal Summary 29
14.1 Asset Purchase 29
14.1.1 QuadraMed Acquires Healthcare Solutions Business From NCR 29
14.2 Private Equity 31
14.2.1 Francisco Partners Completes Acquisition Of Quadramed 31
14.3 Asset Transactions 33
14.3.1 Nuance Communications To Acquire Quantim, Health Information Management Business Of QuadraMed 33
15 Recent Developments 35
15.1 Strategy And Business Planning 35
15.1.1 Aug 16, 2010: QuadraMed Partners With CPMRC To Provide Evidence-Based Clinical Content Within Their Healthcare IT Solutions 35
15.2 Corporate Communications 36
15.2.1 Jan 05, 2010: QuadraMed Appoints Thomas Dunn As Senior Vice President Of Sales And Marketing 36
15.2.2 Sep 01, 2009: QuadraMed Appoints Bonnie Cassidy As Vice President, HIM Consulting Services 36
15.2.3 Jul 27, 2009: QuadraMed Appoint Duncan James As CEO 37
15.3 Product News 37
15.3.1 Oct 26, 2009: QuadraMed CPR Receives License From Four Organizations 37
15.3.2 Jul 07, 2008: QuadraMed Announces General Availability Of Enhanced Version Of QCPR 38
15.4 Other Significant Developments 38
15.4.1 May 11, 2011: QuadraMed Renews Contract With NYCHHC For EHR Upgrade And Support 38
15.4.2 Dec 20, 2010: Texas Organization Of Rural & Community Hospitals Foundation Prepares For ICD-10 Transition With QuadraMed's Products And Services 39
16 Appendix 40
16.1 Research Methodology 41
16.2 Secondary Research 41
16.3 Primary Research 42
16.4 Models 42
16.5 Forecasts 42
16.6 Expert Panels 43
16.7 GlobalData Consulting 43
16.8 Currency Conversion 44
16.9 Contact Us 45
16.10 Disclaimer 45

1.1 List of Tables
Table 1: QuadraMed Corporation, Key Information, 2011 8
Table 2: QuadraMed Corporation, SWOT Analysis, 2011 13
Table 3: Healthcare IT (Clinical IT Systems), Global, Company Share by Revenue ($m), 2011 20
Table 4: QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Region, Revenue ($m) and Market Share (%), 2011 21
Table 5: QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Country, Revenue ($m) and Market Share (%), 2011 22
Table 6: QuadraMed Corporation, Key Employees 23
Table 7: QuadraMed Corporation, Deals Volume Summary, 2006 to YTD 2012 27
Table 8: QuadraMed Corporation, Deals Summary, 2006 to YTD 2012 28
Table 9: QuadraMed Acquires Healthcare Solutions Business From NCR 29
Table 10: Francisco Partners Completes Acquisition Of Quadramed 31
Table 11: Nuance Communications To Acquire Quantim, Health Information Management Business Of QuadraMed 33
Table 12: USD to Local Currency, Average Exchange Rate, 2011 44

1.2 List of Figures
Figure 1: Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 19
Figure 2: QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Country, Market Share (%), 2011 22
Figure 3: QuadraMed Corporation, Deals Volume Summary, 2006 to YTD 2012 27
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Growth in the Indian Watch Industry
    Earlier, in India watches were seen as a luxury item. However, watches are now witnessing a fundamental change in perception, and are now gaining respect as an essential utility item. With the liberalization of the Indian market, coupled with the rising purchasing power of the young and consumerist Indians, watch industry in India seems to [...]
  • Global Retail Ready Packaging Market to Witness Steady Growth
    The market for retail ready packaging has witnessed impressive growth in recent years with boom in the retail industry. Retail ready packaging, also known as shelf-ready packaging is designed for the retail outlet, ready to be placed on shelf without any need for unpacking or repacking. In 2011, the global market for retail packaging was [...]
  • COPD Drug Market Opportunity & Clinical Pipeline Analysis
    Published: 17-Apr-2014        Price: US $2200 Onwards        Pages: 590
    Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the variable airflow and airway hyper-respo......
  • Food Diagnostics Systems Market [By Type (Hybridization, Chromatography, Spectrometry, Biosensor, Immunoassay, Testing Kit)], Consumables Market [By Type (Reagents, Disinfectants, Test Accessories)] & By Geography – Global Trends & Forecast To 2018
    Published: 16-Apr-2014        Price: US $4650 Onwards        Pages: 290
    The food diagnostics market size is projected to increase with rising concerns over food quality and safety, and the implementation of stringent regulations on food safety and foodborne illness prevention. Globalization of food trade has further extended the scope for the food diagnostics market. The emerging markets with increasing demand for food testing are estimated to generate potential opportunities in the market. The food diagnostics market was sub-segmented into diagnostic systems and......
  • 2014 Deep Research Report on Global and China H acid Industry
    Published: 16-Apr-2014        Price: US $2200 Onwards        Pages: 149
    This is a professional and depth research report on Global and China H acid industry. The report firstly introduced H acid basic information included H acid definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, H acid industry policy and plan, H acid product specification, manufacturing process, product cost structure etc. then statis......
  • Fluid Management & Visualization Systems Market by Product (Suction & Irrigation, Dialyzer, Fluid Warming & Waste Management, Endoscopic Camera, Tubing’s, Bloodlines), & Application (GI, Urology, Arthroscopy, Gynecology) – Global Forecasts to 2018
    Published: 16-Apr-2014        Price: US $4650 Onwards        Pages: 360
    The fluid management and visualization systems industry has evolved from traditional standalone systems to modern automated, integrated systems to increase the endosurgical procedure outcomes. Patient safety and security from infections have also gained greater importance in fluid management and visualization systems over the years. Over the past few years, the fluid management and visualization systems market has witnessed a stable growth. The market is expected to grow at a CAGR of 6.1% fro......
  • Lithuania Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 98
    BMI View: We expect the Lithuanian pharmaceutical market to post a five-year compound annual growth rate (CAGR) of 4.4%, rising to a value of LTL2.16bn (US$751mn) in 2018. While double-digit annual growth rates are firmly in the past, some opportunities continue to exist in light of epidemiological factors and an ageing population. The upcoming switch to the euro promises to boost purchasing power and stabilise the pharmaceutical market. However, the Lithuanian market will continue to represent ......
  • Sri Lanka Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 78
    BMI View: A better-than-expected outlook for Sri Lanka's economy has led us to upwardly revise our pharmaceutical and healthcare forecasts. The government has introduced price controls on wholesale and retail prices of imported drugs, which will limit trade. However, the government's focus on imports of lowcost drugs directly from the governments of Bangladesh and Thailand, using the state pharmaceutical corporation, will limit dependency on Indian exporters. Furthermore, the government's streng......
  • Venezuela Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 126
    BMI View: Foreign currency controls and drug price cuts will continue to affect pharmaceutical companies' profitability, with the currency devaluation and high inflation exacerbating the situation. A close relationship and effective communication with the Venezuelan government are vital for the survival of domestic pharmaceutical companies. As the Venezuelan government tries to increase access to medicines, more co-ordination with drug producers to address these issues will become necessary. Hea......
  • Bahrain Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 101
    BMI View: This quarter has seen the beginning of a multi-phased plan by the National Health Regulatory Authority to significantly reduce medicine prices in the country, signalling a potential advancement towards the implementation of a unified Gulf Cooperation Council pricing system. Although less optimistic than before, our medium- and long-term outlooks for the Bahrain pharmaceutical market remain bullish. Medicines uptake will be supported by robust economic growth, in addition to the country......
  • Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2014
    Published: 16-Apr-2014        Price: US $1295 Onwards        Pages: 65
    BMI View: Low health and pharmaceutical expenditures will continue to limit the attractiveness of the pharmaceutical market in Cambodia. Given such a profile, the country will present more commercial benefits to companies dealing with inexpensive generic drugs and over-the-counter products than innovative pharmaceuticals. Headline Expenditure Projections ? Pharmaceuticals: KHR828.7bn (US$210mn) in 2013 to KHR921.9bn (US$230mn) in 2014; +11.2% in local currency terms and +11.8% in US dollar terms......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs